Paris, 21 January 2025 – Essling Capital announces the final closing of its fourth global generalist co-investment fund (ECI 4) at over €120 million, exceeding its initial target of €100 million. At the same time, building on the success of its first thematic fund Essling Co-Invest Healthcare (ECI HC), the management company has already begun marketing its second vintage (ECI HC 2) and is also extending its offer with a new global GP-led secondary strategy.
Successful final closing for the generalist co-investment fund ECI 4
Essling Capital has successfully completed the closing of its fourth global generalist vintage fund, Essling Co-Invest 4 (ECI 4), which was launched at the end of 2023. The fund, that had an initial target of €100 million, was oversubscribed, reaching a total of over €120 million. At final close, ECI 4 already had 8 investments in its portfolio, confirming the team’s ability to execute and the relevance of its positioning in the co-investment market.
Launch of Essling Co-Invest Healthcare ECI HC 2
With 11 deals completed in North America and Europe, the portfolio of the first thematic co- investment fund dedicated to the healthcare sector is developing well and has already been significantly marked up. In light of this strong performance, Essling Capital is continuing to expand in this sector with the launch of its second vintage. The first closing took place in December 2024, and a second close is scheduled for the end of January 2025, with significant initial subscriptions. This new vintage validates the sector expertise developed by the team and its ability to identify and capitalise on attractive investment opportunities in the healthcare sector.
A new GP-led secondary strategy
Capitalising on its expertise in co-investment and its in-depth knowledge of private equity managers, Essling Capital is extending its offering with the launch of a new global strategy dedicated to secondary GP-led continuation vehicle transactions. This initiative leverages the skills developed by the team and responds to a growing market demand for this type of transaction. The fund size would be around €200 million, with an investment period of 2 to 3 years. It is aimed primarily at institutional investors.
“The oversubscription of ECI 4 and the successful launch of our Healthcare Co-Investment fund demonstrate the relevance of our co-investment strategy and the confidence placed in us by our investors,” says Domnin de Kerdaniel, CEO of Essling Capital. “The extension of our offer to secondary GP-led is a natural evolution that builds on our recognised expertise in co- investment and our ability to identify the best opportunities alongside leading fund managers”.
“The secondary GP-led market offers particularly attractive opportunities in the current environment,” adds Arnaud Lipkowicz, Partner and Head of Co-Investment Business. ”Our unique positioning and track record in co-investment allows us to access high-quality deals and continue to create value for our investors”.
In total, Essling’s Co-Investment program has, to date, led to the raise of over €600 million since its launch in 2016 and has enabled the completion of 45 deals alongside leading partners in both Europe and the US. The team screens nearly 300 co-investment deals of all sizes each year.
About Essling Capital
Essling Capital is an independent asset management company specialising in private assets. Essling Capital manages and advises more than €700 million in France and internationally. Essling Capital is regulated by the AMF (Autorité des Marchés Financiers), authorisation no. GP – 17000016.
To better respond to the changing market for private assets, Essling Capital offers its investors innovative investment solutions based on three strategies:
- Co-investment (“Essling Co-Invest”), with generalist or thematic (Healthcare) global co- investment funds and single-asset funds.
- Secondary GP led, with the first global fund being launched in early 2025.
- Lead investment, with Essling Expansion, a Growth Small Cap fund targeting French companies.
Essling Capital’s products are distributed directly or indirectly through, among others, networks of independent IFAs and private banks, and subscribed to by HNWIs, family offices as well as institutions.
• • •
Medias Relations – Essency Communications